It is my pleasure to welcome you to the website of the
Netherlands Cancer Institute (Het Nederlands Kanker Instituut, NKI)
and to introduce you to our mission. Cancer is affecting more
and more people. It is obvious that it is the mission of The
Netherlands Cancer Institute to reduce the burden imposed on so
many by this devastating disease. We perform this mission in close
collaboration with the Antoni van Leeuwenhoek hospital (AVL), a
dedicated cancer hospital. NKI and AVL form an independent
organization under one roof with one board of directors.
The NKI have been accredited the status of Comprehensive Cancer
Center by the OECI.
We believe that we can fulfill our mission best by:
- Conducting fundamental cancer research, translational research,
as well as clinical, epidemiological, and psychosocial research of
the highest quality.
- Providing state-of-the-art diagnostics, treatment, and nursing
care as well as designing and developing new promising treatments
and improving existing ones.
- Transfer of knowledge and skills through education and training
of physicians, scientists and other professionals in the field of
Scientific research is the basis of better cancer treatment. For
a century, the NKI has provided a rich intellectual environment
that supports individual researchers and fosters collaborations
among faculty members, clinicians, postdoctoral fellows, Ph.D.
students, technicians, visiting scientists and trainees. A large
number of non-Dutch scientists working at the Institute contribute
to a stimulating and international atmosphere. The Institute
provides state of the art support facilities, supervised by
dedicated staff. The Institute has a large animal facility with a
special unit for the generation of genetically modified mice, an
animal histology and pathology department, an advanced digital
microscopic facility, a genomics facility for deep sequence
analysis, a biobank and molecular pathology facility, facilities
for high throughput screening, robotics, peptide synthesis, flow
cytometry and protein purification and characterization, and
provides support on tech transfer, grant application and
We provide highly motivated scientists the opportunity to
conduct cutting-edge research and be at the forefront of cancer
research. Many new exciting discoveries lay ahead of us. As a
renowned cancer institute, the NKI has the ambition to make
substantial contributions to this important field, in the firm
belief that this is in the best interest of cancer patients. I hope
the information you find on our website transpires this
René Medema, Ph.D.
Professor of Experimental Oncology
Director of Research
Chairman of the Board of Directors